Imai Takayuki, Kurosawa Koreyuki, Yamaguchi Kayo, Satake Naoko, Asada Yukinori, Matsumoto Ko, Morita Sinkichi, Saijo Satoshi, Aoi Jiro, Fujii Keitaro, Kishimoto Kazuhiro, Goto Takahiro, Matsuura Kazuto
a Department of Head and Neck Surgery , Miyagi Cancer Center , Natori , Miyagi , Japan.
b Department of Plastic Surgery , Miyagi Cancer Center , Natori , Miyagi , Japan.
Acta Otolaryngol. 2018 Jul;138(7):664-669. doi: 10.1080/00016489.2018.1429651. Epub 2018 Jan 31.
Enhanced Recovery After Surgery (ERAS) protocols promote recovery after various invasive surgeries. Likewise, preoperative glucocorticoid administration can reduce complications after some surgeries. However, the effects of ERAS protocols and glucocorticoid administration in patients undergoing major surgery for head and neck cancer have not been well described. The aim of this study was to evaluate the effect of an ERAS protocol with preoperative glucocorticoid administration in major surgery for head and neck cancer.
This retrospective study included 28 patients who underwent major head and neck surgery with free tissue transfer reconstruction at our institution from September 2016 to May 2017, after implementation of an ERAS protocol with preoperative glucocorticoid administration. Outcomes in that group were compared with those in a control group that underwent surgery from January 2015 to September 2016, before implementation of the protocol.
Analysis revealed significantly less body weight fluctuation, lower C-reactive protein levels, higher albumin levels, and lower body temperature in the ERAS group than in the control group postoperatively.
Patients undergoing major surgery for head and neck cancer who were treated with the ERAS protocol and preoperative glucocorticoid administration had evidence of better hemodynamic stability and less inflammatory response than control patients.
加速康复外科(ERAS)方案可促进各种侵入性手术后的恢复。同样,术前给予糖皮质激素可减少某些手术后的并发症。然而,ERAS方案和糖皮质激素给药对头颈部癌大手术患者的影响尚未得到充分描述。本研究的目的是评估ERAS方案联合术前糖皮质激素给药在头颈部癌大手术中的效果。
这项回顾性研究纳入了2016年9月至2017年5月在本机构接受带游离组织移植重建的头颈部大手术的28例患者,这些患者接受了ERAS方案联合术前糖皮质激素给药。将该组的结果与2015年1月至2016年9月在该方案实施前接受手术的对照组的结果进行比较。
分析显示,ERAS组术后体重波动明显小于对照组,C反应蛋白水平更低,白蛋白水平更高,体温更低。
与对照组患者相比,接受ERAS方案联合术前糖皮质激素给药治疗的头颈部癌大手术患者有证据表明其血流动力学稳定性更好,炎症反应更小。